FDA-Inspected Site

LifeLink Foundation, Inc.

7 FDA inspections are on record for LifeLink Foundation, Inc. in Tampa, United States.

483· Form 483 issued

Tampa, United States · Last updated July 10, 2026

Overview

  • 7 FDA inspections are on record.
  • 2 inspections produced a Form 483.
  • The most recent recorded inspection date is 2022-07-15.

At a glance

Inspections

7

Form 483s

2

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
11 Jul 2022 – 15 Jul 2022Biologics483View 483 →
24 Jul 2019 – 30 Jul 2019BiologicsClean
9 May 2018 – 11 May 2018Medical Devices & Rad Health483View 483 →
9 Jan 2017 – 12 Jan 2017BiologicsClean
9 Feb 2015 – 24 Feb 2015BiologicsClean
26 Sep 2012Not recordedClean
3 Sep 2010Not recordedClean

Observations on record

Form 483 observations cited at this site, most recent first.

15 Jul 2022
21 CFR 1271.190(a)

State of repair

Cited by Barbara T Carmichael, Lura D Baquero, Lura D Kelly, Johnathan M Crayton

11 May 2018
21 CFR 820.100(a)

Lack of or inadequate procedures

Cited by Richard K Vogel

11 May 2018
21 CFR 820.50

Purchasing controls, Lack of or inadequate procedures

Cited by Richard K Vogel

11 May 2018
21 CFR 820.75(a)

Lack of or inadequate process validation

Cited by Richard K Vogel

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 1271.190(a)Cited across public-safe Form 483 observations1x
21 CFR 820.100(a)Cited across public-safe Form 483 observations1x
21 CFR 820.50Cited across public-safe Form 483 observations1x
21 CFR 820.75(a)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind LifeLink Foundation, Inc.'s 2 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat